Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
Zonghua Li, Francis Shue, Na Zhao, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Ana‐Caroline Raulin, Sydney V. Doss, Zachary A. Trottier, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 335
TDP-43 Pathology in Alzheimer’s Disease
Axel Meneses, Shunsuke Koga, Justin O’Leary, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 182
The neuroimmune axis of Alzheimer’s disease
Mehdi Jorfi, Anna Maaser-Hecker, Rudolph E. Tanzi
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 170
Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids
Dieter Willbold, Birgit Strodel, Gunnar F. Schröder, et al.
Chemical Reviews (2021) Vol. 121, Iss. 13, pp. 8285-8307
Open Access | Times Cited: 154
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
Rosalía Fernández‐Calle, Sabine C. Konings, Javier Frontiñán-Rubio, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 142
Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer’s disease–associated genes
Matthew J. Moulton, Scott Barish, Isha Ralhan, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 52
Open Access | Times Cited: 119
Cell type-specific roles of APOE4 in Alzheimer disease
Jessica Blumenfeld, Oscar Yip, Min Joo Kim, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 2, pp. 91-110
Open Access | Times Cited: 63
Microglial activation states and their implications for Alzheimer's Disease
Zachary Valiukas, Kathy Tangalakis, Vasso Apostolopoulos, et al.
The Journal of Prevention of Alzheimer s Disease (2025) Vol. 12, Iss. 1, pp. 100013-100013
Open Access | Times Cited: 4
Protective genes and pathways in Alzheimer’s disease: moving towards precision interventions
Mabel Seto, Rebecca L. Weiner, Logan Dumitrescu, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 98
APOE ε4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: a Finnish biobank, autopsy and clinical study
Samu Kurki, Jonas Kantonen, Karri Kaivola, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 68
Alzheimer’s disease – the journey of a healthy brain into organ failure
Todd E. Golde
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 67
APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia
Chia‐Chen Liu, Melissa E. Murray, Xia Li, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 613
Open Access | Times Cited: 66
Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination
Na Wang, Minghui Wang, Suren Jeevaratnam, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 47
Chimeric cerebral organoids reveal the essentials of neuronal and astrocytic APOE4 for Alzheimer’s tau pathology
Shichao Huang, Zhen Zhang, Jun-Wei Cao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 46
Association of APOE Genotypes and Chronic Traumatic Encephalopathy
Kathryn Atherton, Xudong Han, Jaeyoon Chung, et al.
JAMA Neurology (2022) Vol. 79, Iss. 8, pp. 787-787
Open Access | Times Cited: 46
APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients
Hongsheng Zhang, Lin Shao, Zhihao Lin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 46
APOE effects on regional tau in preclinical Alzheimer’s disease
Christina B. Young, Emily Johns, Gabriel Kennedy, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 39
Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease
Muhammad Ali, Derek B. Archer, Priyanka Gorijala, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 30
Mitochondria in Aging and Alzheimer’s Disease: Focus on Mitophagy
Jangampalli Adi Pradeepkiran, Javaria Baig, Ann Seman, et al.
The Neuroscientist (2023) Vol. 30, Iss. 4, pp. 440-457
Closed Access | Times Cited: 29
Apolipoprotein E4 has extensive conformational heterogeneity in lipid-free and lipid-bound forms
Melissa D. Stuchell‐Brereton, Maxwell I. Zimmerman, Justin J. Miller, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 7
Open Access | Times Cited: 29
The shared role of cholesterol in neuronal and peripheral inflammation
Scott B. Hansen, Hao Wang
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108486-108486
Open Access | Times Cited: 27
Evaluation and targeting of amyloid precursor protein (APP)/amyloid beta (Aβ) axis in amyloidogenic and non-amyloidogenic pathways: A time outside the tunnel
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102119-102119
Closed Access | Times Cited: 26
Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond
Elise K. Webber, Marc Fivaz, Grace E. Stutzmann, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 8, pp. 3701-3717
Open Access | Times Cited: 23
Updates in Alzheimer's disease: from basic research to diagnosis and therapies
Enjie Liu, Yao Zhang, Jian–Zhi Wang
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Is CAA a perivascular brain clearance disease? A discussion of the evidence to date and outlook for future studies
Susanne J. van Veluw, Helene Benveniste, Erik N.T.P. Bakker, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top